DKSH Selected as Medigen’s COVID-19 Vaccine Distribution Partner in Taiwan August 24, 2021


			
				DKSH Selected as Medigen’s COVID-19 Vaccine Distribution Partner in Taiwan

DKSH Business Unit Healthcare has entered into a partnership with Medigen Vaccine Biologics Corporation to ensure that their COVID-19 vaccines are speedily delivered and well protected throughout the entire cold chain.

Media release 

DKSH Selected as Medigen’s COVID-19 Vaccine Distribution Partner in Taiwan

DKSH Business Unit Healthcare has entered into a partnership with Medigen Vaccine Biologics Corporation to ensure that their COVID-19 vaccines are speedily delivered and well protected throughout the entire cold chain.

Bangkok, Thailand, August 24, 2021 – DKSH Business Unit Healthcare, the leading partner for healthcare companies seeking to grow their business in Asia and beyond, will offer complete vaccine cold chain solutions for Medigen, a biopharmaceutical company in Taiwan. The range of services will include storage, distribution, delivery as well as value-added services, such as labeling and repackaging. Together with a dedicated healthcare delivery team covering all regions of Taiwan, DKSH will be providing storage in a two-to-eight-degree Celsius environment for Medigen’s temperature-sensitive COVID-19 vaccines in the company’s brand-new cold chain facility. The cold chain facility is certified by the Ministry of Health and Welfare’s Pharmaceutical Inspection Co-operation Scheme for Good Manufacturing and Distribution Practices (PIC/S GMP and PIC/S GDP) licenses to ensure the quality of the product is protected throughout the entire supply chain process.

 

Leo Lee, Executive Vice President of Medigen, indicated: “DKSH Taiwan has been serving the healthcare industry for more than 20 years. With a highly professional, dedicated team and an extensive healthcare supply chain network covering hospitals, clinics and all levels of healthcare service outlets, we are confident that DKSH will speedily and reliably deliver the vaccine to the right locations for people to be vaccinated in a timely manner.”

 

Wennie Chang, Vice President, Business Unit Healthcare, DKSH Taiwan, shared: “Medigen’s successful development of COVID-19 vaccines has established a remarkable milestone in the biotechnology industry. It is our great honor to work with Medigen to contribute to the goal of healthcare for all and help our society alleviate the impacts of the pandemic.” 

 

In addition to the brand-new cold chain facility, DKSH has a PIC/S GDP and PIC/S GDP certified multi-temperature healthcare distribution center and two depots, all supported by a dedicated healthcare delivery team.